Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Delivery Systems | 6 | 2023 | 2219 | 0.880 |
Why?
|
| Lenses | 1 | 2022 | 45 | 0.860 |
Why?
|
| Lens, Crystalline | 1 | 2022 | 388 | 0.740 |
Why?
|
| Microtechnology | 1 | 2019 | 70 | 0.680 |
Why?
|
| Antineoplastic Agents | 9 | 2023 | 13695 | 0.640 |
Why?
|
| Prostheses and Implants | 3 | 2021 | 1387 | 0.610 |
Why?
|
| Neoplasms, Experimental | 3 | 2021 | 1276 | 0.600 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2018 | 247 | 0.560 |
Why?
|
| Phantoms, Imaging | 2 | 2021 | 2480 | 0.510 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 1071 | 0.450 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2016 | 730 | 0.450 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2019 | 1018 | 0.390 |
Why?
|
| Cerebellar Neoplasms | 1 | 2016 | 587 | 0.390 |
Why?
|
| Carcinoma | 1 | 2023 | 2375 | 0.390 |
Why?
|
| Medulloblastoma | 1 | 2016 | 683 | 0.380 |
Why?
|
| Apoptosis | 5 | 2022 | 9727 | 0.370 |
Why?
|
| Cell Line, Tumor | 16 | 2022 | 16689 | 0.350 |
Why?
|
| Drug Monitoring | 1 | 2015 | 956 | 0.330 |
Why?
|
| Melanoma | 2 | 2018 | 5510 | 0.330 |
Why?
|
| Glioma | 1 | 2023 | 3401 | 0.320 |
Why?
|
| Glioblastoma | 1 | 2023 | 3481 | 0.320 |
Why?
|
| Neoplasms | 7 | 2022 | 21683 | 0.300 |
Why?
|
| Mice, Nude | 4 | 2018 | 3689 | 0.300 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2016 | 2043 | 0.270 |
Why?
|
| Cytoskeleton | 1 | 2010 | 1185 | 0.260 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2018 | 5535 | 0.240 |
Why?
|
| Actins | 2 | 2016 | 2121 | 0.240 |
Why?
|
| Pregnancy Outcome | 6 | 1993 | 2795 | 0.220 |
Why?
|
| Neuropilin-1 | 1 | 2023 | 90 | 0.210 |
Why?
|
| Doxorubicin | 3 | 2018 | 2234 | 0.210 |
Why?
|
| Tumor Microenvironment | 4 | 2023 | 3586 | 0.200 |
Why?
|
| Nitroquinolines | 1 | 2020 | 4 | 0.200 |
Why?
|
| Mice | 15 | 2023 | 81183 | 0.190 |
Why?
|
| Galectin 3 | 1 | 2023 | 227 | 0.190 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2020 | 5172 | 0.180 |
Why?
|
| Animals | 18 | 2023 | 168757 | 0.180 |
Why?
|
| Drug Synergism | 3 | 2020 | 1792 | 0.180 |
Why?
|
| Enzyme Inhibitors | 3 | 2020 | 3798 | 0.170 |
Why?
|
| Chickens | 1 | 2021 | 865 | 0.170 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2020 | 3557 | 0.170 |
Why?
|
| Intercalating Agents | 1 | 2018 | 34 | 0.170 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2023 | 1155 | 0.170 |
Why?
|
| Nucleotidyltransferases | 1 | 2020 | 220 | 0.160 |
Why?
|
| Photons | 1 | 2022 | 588 | 0.160 |
Why?
|
| Metal Nanoparticles | 1 | 2022 | 405 | 0.160 |
Why?
|
| Growth Inhibitors | 1 | 2019 | 385 | 0.160 |
Why?
|
| South Australia | 6 | 1993 | 19 | 0.150 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2016 | 503 | 0.150 |
Why?
|
| Genes, erbB-2 | 1 | 2018 | 162 | 0.150 |
Why?
|
| Obstetric Labor Complications | 4 | 1992 | 238 | 0.150 |
Why?
|
| Workflow | 1 | 2021 | 847 | 0.140 |
Why?
|
| Pinocytosis | 1 | 2016 | 65 | 0.140 |
Why?
|
| bcl-X Protein | 1 | 2018 | 411 | 0.140 |
Why?
|
| Receptors, Androgen | 1 | 2023 | 1058 | 0.140 |
Why?
|
| Caspase 3 | 1 | 2018 | 758 | 0.140 |
Why?
|
| Apgar Score | 3 | 1991 | 123 | 0.140 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2017 | 1634 | 0.140 |
Why?
|
| Karyopherins | 1 | 2016 | 137 | 0.130 |
Why?
|
| Cerebral Palsy | 2 | 1990 | 459 | 0.130 |
Why?
|
| Microfilament Proteins | 2 | 2016 | 1152 | 0.120 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2017 | 640 | 0.120 |
Why?
|
| Serum Albumin | 1 | 2016 | 676 | 0.120 |
Why?
|
| Maternal Age | 3 | 1992 | 802 | 0.110 |
Why?
|
| Pregnancy, High-Risk | 2 | 1991 | 120 | 0.110 |
Why?
|
| Deoxycytidine | 1 | 2017 | 826 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2016 | 538 | 0.110 |
Why?
|
| Breech Presentation | 1 | 1993 | 44 | 0.110 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2016 | 624 | 0.110 |
Why?
|
| Breast Neoplasms | 3 | 2018 | 20822 | 0.110 |
Why?
|
| Endoscopy | 1 | 2022 | 1785 | 0.110 |
Why?
|
| Calibration | 1 | 2015 | 816 | 0.110 |
Why?
|
| Small-Area Analysis | 1 | 1992 | 55 | 0.100 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 871 | 0.100 |
Why?
|
| Rare Diseases | 1 | 2016 | 553 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 1434 | 0.100 |
Why?
|
| Pregnancy Complications | 5 | 1992 | 2861 | 0.100 |
Why?
|
| Amino Acids | 1 | 2016 | 1736 | 0.090 |
Why?
|
| Humans | 33 | 2023 | 744343 | 0.090 |
Why?
|
| Antibodies | 1 | 2018 | 2460 | 0.090 |
Why?
|
| Benzodiazepines | 1 | 2016 | 1101 | 0.090 |
Why?
|
| Protein Kinases | 1 | 2017 | 1640 | 0.090 |
Why?
|
| Microscopy, Atomic Force | 1 | 2010 | 250 | 0.090 |
Why?
|
| Polyethylene Glycols | 1 | 2015 | 1182 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 2 | 2017 | 5256 | 0.090 |
Why?
|
| Cell Physiological Phenomena | 1 | 2010 | 154 | 0.080 |
Why?
|
| Paclitaxel | 1 | 2016 | 1708 | 0.080 |
Why?
|
| Molecular Imaging | 1 | 2016 | 828 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2022 | 4042 | 0.080 |
Why?
|
| Elasticity | 1 | 2010 | 657 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2019 | 4554 | 0.080 |
Why?
|
| Extracellular Matrix | 1 | 2016 | 1741 | 0.080 |
Why?
|
| Polymers | 1 | 2015 | 1621 | 0.080 |
Why?
|
| Parity | 1 | 1991 | 929 | 0.080 |
Why?
|
| Indoles | 1 | 2016 | 1839 | 0.080 |
Why?
|
| Pyrimidines | 1 | 2019 | 2942 | 0.070 |
Why?
|
| Cell Movement | 2 | 2016 | 5217 | 0.070 |
Why?
|
| Gene Expression | 2 | 2016 | 7799 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2016 | 1938 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 2938 | 0.070 |
Why?
|
| Stress, Mechanical | 1 | 2010 | 1686 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 11366 | 0.060 |
Why?
|
| Sarcoma | 1 | 2016 | 1897 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5221 | 0.060 |
Why?
|
| Social Class | 1 | 1992 | 1999 | 0.060 |
Why?
|
| Biopsy | 1 | 2015 | 6756 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 2699 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 10943 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11524 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 4838 | 0.050 |
Why?
|
| Orosomucoid | 1 | 2001 | 45 | 0.050 |
Why?
|
| Neoplasm Metastasis | 3 | 2016 | 4851 | 0.050 |
Why?
|
| Disease Models, Animal | 5 | 2018 | 18029 | 0.050 |
Why?
|
| Cesarean Section | 1 | 1989 | 1365 | 0.050 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2023 | 273 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 12261 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2010 | 4161 | 0.040 |
Why?
|
| Female | 16 | 2019 | 380194 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2018 | 23403 | 0.040 |
Why?
|
| Gold | 1 | 2022 | 484 | 0.040 |
Why?
|
| RNA Interference | 2 | 2019 | 2889 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 13102 | 0.040 |
Why?
|
| Australia | 3 | 1989 | 1170 | 0.040 |
Why?
|
| Mycoplasma hyorhinis | 1 | 2017 | 8 | 0.040 |
Why?
|
| Cell Cycle | 2 | 2016 | 2967 | 0.040 |
Why?
|
| Gammaproteobacteria | 1 | 2017 | 29 | 0.040 |
Why?
|
| Prognosis | 2 | 2016 | 29063 | 0.040 |
Why?
|
| Mitosis | 1 | 2023 | 1208 | 0.040 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2020 | 486 | 0.040 |
Why?
|
| DNA Repair Enzymes | 1 | 2019 | 349 | 0.040 |
Why?
|
| Pregnancy | 8 | 1993 | 29144 | 0.040 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2019 | 431 | 0.040 |
Why?
|
| Receptor, erbB-3 | 1 | 2018 | 142 | 0.040 |
Why?
|
| Chromatography, Gas | 1 | 2016 | 156 | 0.040 |
Why?
|
| Nitrogen Isotopes | 1 | 2016 | 84 | 0.040 |
Why?
|
| Infant Mortality | 2 | 1993 | 754 | 0.040 |
Why?
|
| Cell Survival | 2 | 2017 | 5882 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2020 | 1266 | 0.040 |
Why?
|
| Plasmapheresis | 1 | 2016 | 211 | 0.030 |
Why?
|
| Integrin alpha5beta1 | 1 | 2016 | 38 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2017 | 261 | 0.030 |
Why?
|
| Ipecac | 1 | 1975 | 26 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2019 | 63114 | 0.030 |
Why?
|
| Tubulin | 1 | 2019 | 695 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 11124 | 0.030 |
Why?
|
| Protein Binding | 2 | 2019 | 9386 | 0.030 |
Why?
|
| Androgens | 1 | 2023 | 1281 | 0.030 |
Why?
|
| Accidents, Home | 1 | 1975 | 75 | 0.030 |
Why?
|
| First Aid | 1 | 1975 | 65 | 0.030 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2016 | 271 | 0.030 |
Why?
|
| Extracellular Space | 1 | 2016 | 594 | 0.030 |
Why?
|
| Hydrazines | 1 | 2016 | 226 | 0.030 |
Why?
|
| Models, Statistical | 1 | 1989 | 5102 | 0.030 |
Why?
|
| Delivery, Obstetric | 2 | 1992 | 906 | 0.030 |
Why?
|
| Anesthetics, Local | 1 | 2001 | 985 | 0.030 |
Why?
|
| Cisplatin | 1 | 2020 | 1662 | 0.030 |
Why?
|
| Infant, Newborn | 5 | 1993 | 25625 | 0.030 |
Why?
|
| Albumins | 1 | 2016 | 569 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2018 | 578 | 0.030 |
Why?
|
| Forecasting | 1 | 2023 | 2951 | 0.030 |
Why?
|
| DNA Replication | 1 | 2020 | 1399 | 0.030 |
Why?
|
| Poisoning | 1 | 1975 | 249 | 0.030 |
Why?
|
| Hospitals, Special | 1 | 1974 | 101 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 1655 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2001 | 1917 | 0.030 |
Why?
|
| Labor Onset | 1 | 1992 | 16 | 0.030 |
Why?
|
| Quinolines | 1 | 2018 | 732 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 6314 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 2085 | 0.030 |
Why?
|
| Fibronectins | 1 | 2016 | 726 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 944 | 0.030 |
Why?
|
| Divorce | 1 | 1992 | 79 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2017 | 2716 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2016 | 1730 | 0.030 |
Why?
|
| Mutation | 1 | 2016 | 29786 | 0.020 |
Why?
|
| Quinazolines | 1 | 2018 | 1356 | 0.020 |
Why?
|
| DNA Repair | 1 | 2020 | 2046 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2022 | 1905 | 0.020 |
Why?
|
| Marital Status | 1 | 1992 | 437 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2018 | 1783 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2016 | 1915 | 0.020 |
Why?
|
| Microtubules | 1 | 2016 | 1090 | 0.020 |
Why?
|
| DNA Damage | 1 | 2020 | 2432 | 0.020 |
Why?
|
| Triazoles | 1 | 2016 | 911 | 0.020 |
Why?
|
| Hospitals, Urban | 1 | 1992 | 499 | 0.020 |
Why?
|
| Mental Disorders | 1 | 1989 | 6600 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 1526 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2017 | 2382 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2018 | 2455 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 6386 | 0.020 |
Why?
|
| Length of Stay | 2 | 1992 | 6309 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 2012 | 0.020 |
Why?
|
| Prenatal Care | 2 | 1992 | 1092 | 0.020 |
Why?
|
| Receptor, erbB-2 | 1 | 2018 | 2416 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 2727 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2019 | 3462 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 1992 | 1179 | 0.020 |
Why?
|
| Logistic Models | 2 | 1993 | 13408 | 0.020 |
Why?
|
| Collagen | 1 | 2016 | 2689 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 1992 | 12245 | 0.020 |
Why?
|
| Computational Biology | 1 | 2019 | 3521 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2022 | 4445 | 0.020 |
Why?
|
| DNA | 1 | 2020 | 7301 | 0.020 |
Why?
|
| Piperazines | 1 | 2016 | 2488 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2020 | 5853 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 2541 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 6538 | 0.020 |
Why?
|
| Random Allocation | 1 | 1989 | 2429 | 0.020 |
Why?
|
| Bone Marrow Diseases | 1 | 1966 | 231 | 0.020 |
Why?
|
| Pyridines | 1 | 2016 | 2825 | 0.020 |
Why?
|
| Intelligence | 1 | 1989 | 920 | 0.020 |
Why?
|
| Urban Population | 1 | 1992 | 2021 | 0.020 |
Why?
|
| Birth Weight | 1 | 1992 | 2069 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1993 | 6365 | 0.010 |
Why?
|
| Gestational Age | 1 | 1992 | 3493 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 9438 | 0.010 |
Why?
|
| Risk Factors | 4 | 1992 | 72290 | 0.010 |
Why?
|
| Adult | 6 | 1993 | 214055 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 8428 | 0.010 |
Why?
|
| Aging | 1 | 2020 | 8664 | 0.010 |
Why?
|
| Proteins | 1 | 2016 | 6103 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2017 | 10481 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 2001 | 313 | 0.010 |
Why?
|
| Male | 4 | 2023 | 350118 | 0.010 |
Why?
|
| Genomics | 1 | 2016 | 5720 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2001 | 1157 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2001 | 689 | 0.010 |
Why?
|
| Odds Ratio | 1 | 1992 | 9849 | 0.010 |
Why?
|
| Disease Progression | 1 | 2016 | 13284 | 0.010 |
Why?
|
| Pediatrics | 1 | 1974 | 3475 | 0.010 |
Why?
|
| Age Factors | 2 | 1992 | 18370 | 0.010 |
Why?
|
| Sex Factors | 1 | 1993 | 10397 | 0.010 |
Why?
|
| Liver Diseases | 1 | 1966 | 1253 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2016 | 9239 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 1992 | 7785 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 1974 | 7659 | 0.010 |
Why?
|
| Child, Preschool | 3 | 1989 | 41006 | 0.010 |
Why?
|
| Drug Labeling | 1 | 1975 | 233 | 0.010 |
Why?
|
| Infant | 2 | 1989 | 35136 | 0.010 |
Why?
|
| Vomiting | 1 | 1975 | 636 | 0.010 |
Why?
|
| Family Practice | 1 | 1974 | 516 | 0.010 |
Why?
|
| Drug Therapy | 1 | 1974 | 497 | 0.010 |
Why?
|
| Organizations | 1 | 1951 | 170 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 1989 | 77449 | 0.010 |
Why?
|
| Morbidity | 1 | 1974 | 1769 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1989 | 39050 | 0.000 |
Why?
|
| Niemann-Pick Diseases | 1 | 1966 | 28 | 0.000 |
Why?
|
| Pigments, Biological | 1 | 1966 | 53 | 0.000 |
Why?
|
| Histiocytes | 1 | 1966 | 103 | 0.000 |
Why?
|
| Research Design | 1 | 2001 | 5987 | 0.000 |
Why?
|
| Drug Prescriptions | 1 | 1974 | 1637 | 0.000 |
Why?
|
| Residence Characteristics | 1 | 1974 | 2050 | 0.000 |
Why?
|
| Time Factors | 2 | 1975 | 40075 | 0.000 |
Why?
|
| Referral and Consultation | 1 | 1974 | 3528 | 0.000 |
Why?
|
| Child | 3 | 1975 | 77709 | 0.000 |
Why?
|
| Diarrhea | 1 | 1966 | 1348 | 0.000 |
Why?
|
| Respiratory Tract Infections | 1 | 1966 | 961 | 0.000 |
Why?
|
| Hospitalization | 1 | 1974 | 10262 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1966 | 12959 | 0.000 |
Why?
|
| Adolescent | 1 | 1974 | 85781 | 0.000 |
Why?
|
Concepts
(259)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(46)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_